We studied five pathological specimens from five patients at 1.5, 3.0, 4.0, 13.5, and 14.0 months after radiotherapy for HCC. Four needle biopsies were obtained to investigate liver parenchyma of focal liver reaction (FLR) around treated HCC, when patients had newly developed HCC or local recurrence appeared in the liver. Liver resection was performed in one case where insufficient radiotherapy effect for HCC was suspected. In all patients, FLR was recognized as a hypervascular area around the HCC on enhanced CT and enhanced Gd-EOB-DTPA (EOB-MRI). Liver specimens were analyzed to assess the pathological characteristics of FLR. FLR was recognized as prolonged liver enhancement in enhanced CT and EOB-MRI. From pathological understanding, sinu...
Transarterial chemoembolization (TACE) is one of the standard therapies for bridging patients with h...
BACKGROUND: Radiofrequency ablation (RFA) is a novel technique for the treatment of liver malignanci...
<p><b>A</b>) Type 1 (case 12, 10 months following SBRT). a) Dose distribution b) Plain c) Arterial p...
BackgroundProton beam therapy (PBT) achieves good local control for hepatocellular carcinoma (HCC), ...
Focal liver reaction (FLR) appears in the hepatobiliary-phase images of gadolinium-ethoxybenzyl-diet...
Aim: The purpose of the present study was to analyze hepatic toxicity following radiotherapy combine...
Proton beam therapy (PBT) achieves good local control for hepatocellular carcinoma (HCC), and toxici...
Purpose: To characterize and quantitatively assess focal radiation reactions in the liver after ster...
Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new ...
Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes...
Purpose: To evaluate temporal changes in contrast enhancement patterns of non-tumorous hepatic paren...
Background Knowledge that liver tumours preferentially take their blood supply from the arterial blo...
We describe an unusual complication after Radiofrequency ablation of Hepatocellular Carcinoma (HCC)....
Hepatic veno-occlusive disease (VOD) is a rare disease due to occlusion of the terminal hepatic venu...
Following transcatheter arterial chemoembolisation (TACE), the appearances on CT or MR images are la...
Transarterial chemoembolization (TACE) is one of the standard therapies for bridging patients with h...
BACKGROUND: Radiofrequency ablation (RFA) is a novel technique for the treatment of liver malignanci...
<p><b>A</b>) Type 1 (case 12, 10 months following SBRT). a) Dose distribution b) Plain c) Arterial p...
BackgroundProton beam therapy (PBT) achieves good local control for hepatocellular carcinoma (HCC), ...
Focal liver reaction (FLR) appears in the hepatobiliary-phase images of gadolinium-ethoxybenzyl-diet...
Aim: The purpose of the present study was to analyze hepatic toxicity following radiotherapy combine...
Proton beam therapy (PBT) achieves good local control for hepatocellular carcinoma (HCC), and toxici...
Purpose: To characterize and quantitatively assess focal radiation reactions in the liver after ster...
Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new ...
Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes...
Purpose: To evaluate temporal changes in contrast enhancement patterns of non-tumorous hepatic paren...
Background Knowledge that liver tumours preferentially take their blood supply from the arterial blo...
We describe an unusual complication after Radiofrequency ablation of Hepatocellular Carcinoma (HCC)....
Hepatic veno-occlusive disease (VOD) is a rare disease due to occlusion of the terminal hepatic venu...
Following transcatheter arterial chemoembolisation (TACE), the appearances on CT or MR images are la...
Transarterial chemoembolization (TACE) is one of the standard therapies for bridging patients with h...
BACKGROUND: Radiofrequency ablation (RFA) is a novel technique for the treatment of liver malignanci...
<p><b>A</b>) Type 1 (case 12, 10 months following SBRT). a) Dose distribution b) Plain c) Arterial p...